Cadence Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
17,466
+9,225
| +112% | +$1.02M | 0.13% | 120 |
|
|
2025
Q1 | $923K | Buy |
8,241
+139
| +2% | +$15.6K | 0.07% | 164 |
|
|
2024
Q4 | $748K | Sell |
8,102
-114,867
| -93% | -$10.6M | 0.05% | 184 |
|
|
2024
Q3 | $10.3M | Buy |
122,969
+3,800
| +3% | +$319K | 0.71% | 31 |
|
|
2024
Q2 | $8.18M | Buy |
119,169
+1,826
| +2% | +$125K | 0.61% | 34 |
|
|
2024
Q1 | $8.6M | Sell |
117,343
-193
| -0.2% | -$14.1K | 0.63% | 37 |
|
|
2023
Q4 | $9.52M | Buy |
117,536
+542
| +0.5% | +$43.9K | 0.77% | 29 |
|
|
2023
Q3 | $8.77M | Sell |
116,994
-16
| -0% | -$1.2K | 0.77% | 31 |
|
|
2023
Q2 | $9.02M | Buy |
117,010
+4,034
| +4% | +$311K | 0.79% | 27 |
|
|
2023
Q1 | $9.37M | Sell |
112,976
-1,104
| -1% | -$91.6K | 0.86% | 25 |
|
|
2022
Q4 | $9.79M | Buy |
114,080
+348
| +0.3% | +$29.9K | 0.9% | 23 |
|
|
2022
Q3 | $7.02M | Buy |
113,732
+3,550
| +3% | +$219K | 0.73% | 29 |
|
|
2022
Q2 | $6.81M | Buy |
110,182
+3,607
| +3% | +$223K | 0.98% | 31 |
|
|
2022
Q1 | $6.34M | Buy |
+106,575
| New | +$6.34M | 0.79% | 40 |
|
|
2020
Q2 | – | Sell |
-3,303
| Closed | -$247K | – | 185 |
|
|
2020
Q1 | $247K | Sell |
3,303
-51,644
| -94% | -$3.86M | 0.06% | 154 |
|
|
2019
Q4 | $3.57M | Buy |
+54,947
| New | +$3.57M | 0.66% | 46 |
|
|
2018
Q1 | – | Sell |
-46,033
| Closed | -$3.3M | – | 249 |
|
|
2017
Q4 | $3.3M | Buy |
+46,033
| New | +$3.3M | 0.31% | 45 |
|